| Cytisine Versus Varenicline for Smoking Cessation | RAUORA: Cytisine Versus Varenicline for Smoking Cessation | NCT02957786 |
| A non-inferiority trial of cytisine versus varenicline for smoking cessation | A randomised controlled non-inferiority clinical trial to evaluate the cost-effectiveness and safety of cytisine compared to varenicline as a treatment for people who wish to stop smoking | ACTRN12616001654448 |
| A 26-day study of cytisine (Tabex®) with multiple evaluations in people who smoke. | Repeat-Dose Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers - Repeat-Dose PK and PD Evaluation of Cytisine in Healthy Smokers | EUCTR2017-003257-42-GB |
| A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine | A Phase 1 Open Label, Randomized, Two-Way Crossover Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of Cytisine | NCT03268343 |
| A Single Dose-escalation Study of Cytisine in Adult Smokers | A Phase I, Double-blind, Randomized, Placebo-controlled, Single Dose-escalation Study to Evaluate the Tolerability and Safety of Cytisine in Adult Smokers | NCT03848208 |
| Cytisine as a smoking cessation aid: measuring blood levels, craving, withdrawal and mood over a course of treatment | Cytisine as a smoking cessation aid: measuring blood levels, craving, withdrawal and mood over a course of treatment | ACTRN12613000002785 |
| Efficacy of CYTISINE for Smoking Cessation through Downward Titration versus Simplified Three times daily Regimen : Open-label Randomized Clinical Trial | Efficacy of CYTISINE for Smoking Cessation through Downward Titration versus Simplified Three times daily Regimen : Open-label Randomized Clinical Trial | TCTR20240711001 |
| CASCAID Study: Cytisine as a smoking cessation aid | A single-blind randomised controlled non-inferiority clinical trial to evaluate the efficacy and safety of cytisine compared to usual care (21mg, 14mg, or 7mg nicotine patch, 4mg or 2mg nicotine gum or 2mg or 1mg nicotine lozenge nicotine replacement therapy (NRT) plus behavioural support) as a treatment for people who wish to stop smoking | ACTRN12610000590066 |
| The effect of Tabex (Cytisine) on success of attempts to stop smoking | | ISRCTN37568749 |
| A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation | A Phase 1 Open Label, Randomized, Two-Way Crossover Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation | NCT03509948 |
| Trial of Cytisine in Adult Smokers | A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2b Trial of Cytisine in Adult Smokers | NCT03709823 |
| Cytisine for nicotine-containing electronic cigarette and tobacco cigarette cessation: a randomized placebo-controlled trial | Cytisine for nicotine-containing electronic cigarette and tobacco cigarette cessation: a randomized placebo-controlled trial - CYT03-2021 | CTIS2023-504708-27-00 |
| Cytisine for Smoking Cessation | Cytisine: Testing Its Potential as a Therapeutic Strategy for Smoking Cessation Among People With Concurrent Alcohol Use Disorder | NCT05729243 |
| Cytisine Compared to Combination NRT in Relapsed Smokers | Pilot RCT of Cytisine Compared to Combination Nicotine Replacement Therapy to Reduce Cigarette Consumption in Relapsed Smokers | NCT04286295 |
| Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting | Varenicline Versus Cytisine for Smoking Cessation in the Primary Care Setting in Croatia and Slovenia - a Randomized Controlled Trial | NCT04015414 |
| Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4) | Cytisine as a Smoking Cessation Agent: Improving Adherence Through a Better Understanding of Pharmacokinetics and Dose Response | NCT02585024 |
| Analysis and Evaluation of Smoking Treatment With Cytisine | Analysis and Evaluation of Smoking Treatment With Cytisine: Retrospective Observational Study | NCT06439303 |
| Efficacy safety and Health-Related Quality of Life (HRQoL) of cytisine in Smoking cessation | A Double-blinded Randomized Controlled Trial. | TCTR20180312001 |
| Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation | Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation: A Randomized Controlled Trial | NCT06832085 |
| A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers | Repeat-Dose Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers | NCT03303911 |
| PHARMACODYNAMIC EFFECTS OF NICOTINE MOUTH SPRAY AND CYTISINE TABLET. A STUDY IN HEALTHY SMOKERS. | PHARMACODYNAMIC EFFECTS OF NICOTINE MOUTH SPRAY AND CYTISINE TABLET. A STUDY IN HEALTHY SMOKERS. | EUCTR2016-001267-36-SE |
| Cytisine and E-cigarettes With Supportive Text-messaging for Smoking Cessation (Cess@Tion) | Cytisine and E-cigarettes With Supportive Text-messaging for Smoking Cessation | NCT05311085 |
| Cytisine versus nicotine for smoking cessation in hospitalized psychiatric patients. | Cytisine versus nicotine for smoking cessation in hospitalized psychiatric patients. | IRCT20100127003210N16 |
